FDA Inspection 1096669 — Matrix Pharmacorp Private Limited

Matrix Pharmacorp Private Limited — FEI 3002785310

The FDA completed an inspection of Matrix Pharmacorp Private Limited on June 5, 2019 in Gaitula Chodavaram. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 5, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Gaitula Chodavaram (India)